Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
about
Telemedicine for acute ischaemic strokeCerebrolysin for acute ischaemic strokeEvaluation of Gene Therapy as an Intervention Strategy to Treat Brain Injury from StrokeRandomized controlled trials - a matter of designEndovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis.Combined neurothrombectomy or thrombolysis with adjunctive delivery of 3K3A-activated protein C in acute ischemic strokeIntravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom OnsetCase characteristics, hyperacute treatment, and outcome information from the clinical research center for stroke-fifth division registry in South KoreaEvidence for the prevention and treatment of stroke in dialysis patientsThe fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995-2015Diagnosis and management of acute ischemic stroke: speed is criticalRecombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-AnalysisHospitals admitting at least 100 patients with stroke a year should have a stroke unit: a case study from AustraliaCardioembolic Stroke.Cerebrolysin for acute ischaemic stroke.Review article: Why is there still a debate regarding the safety and efficacy of intravenous thrombolysis in the management of presumed acute ischaemic stroke? A systematic review and meta-analysis.Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection.NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): Randomized Controlled Contrast-Enhanced Sonothrombolysis in an Unselected Acute Ischemic Stroke Population.Therapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke.A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential metIntravenous thrombolysis for acute ischaemic stroke in the elderly: data from the Baden-Wuerttemberg stroke registry.Safety and Efficacy of Solitaire Stent Thrombectomy: Individual Patient Data Meta-Analysis of Randomized Trials.Stroke Treatment Academic Industry Roundtable Recommendations for Individual Data Pooling Analyses in StrokePower of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data.Thrombolytic Treatment for Ischaemic Stroke: Could the Crisis of Confidence Have Been Avoided by Better Analysis of Trial Data?Efficacy and safety of desmoteplase in acute ischemic stroke patients: A systematic review and meta-analysis.Under-representation of women in stroke randomized controlled trials: inadvertent selection bias leading to suboptimal conclusions.Pretreatment with Sodium Phenylbutyrate Alleviates Cerebral Ischemia/Reperfusion Injury by Upregulating DJ-1 Protein.Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage.Reasons and evolution of non-thrombolysis in acute ischaemic stroke.Effect of alteplase within 6 hours of acute ischemic stroke on all-cause mortality (third International Stroke Trial).Regional availability of mechanical embolectomy for acute ischemic stroke in California, 2009 to 2010.Mitochondrial DNA haplogroups and short-term neurological outcomes of ischemic strokeFactors Associated with Early Hospital Arrival in Patients with Acute Ischemic Stroke.A possible new focus for stroke treatment - migrating stem cellsIntravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand (1981-2012): A Multi-Ethnic Population-Based Series of StudiesCopeptin: Limited Usefulness in Early Stroke Differentiation?Development of a decision analytic model to support decision making and risk communication about thrombolytic treatmentFactors Associated with In-Hospital Delay in Intravenous Thrombolysis for Acute Ischemic Stroke: Lessons from China.
P2860
Q24186225-4615AE1A-AF32-4DF6-81DD-3D06FC263C04Q24187130-B9694394-7BC2-4F4D-B201-4DCC189741C5Q26744103-942B0280-5C8C-4909-ABFD-EA30AC9EFE5AQ26746217-7ECA4EB6-907F-4FAB-AD66-9AE6A6B4A54FQ26752659-4157B8ED-9D1E-4B8C-83FF-84609A8140F8Q26782990-6C82939A-602B-443A-BB9C-E556F861C3AEQ26796477-9E8909C2-8E91-4117-BD9A-1CFEB7F66864Q27011252-D344A363-A787-4CDA-A518-816E4566E21AQ27023274-CC6DD3C5-F90A-4905-B460-8678BEC540D6Q28069442-0068612B-3714-4906-8CF8-44828B2528A9Q28085439-648696ED-809C-40BC-92CF-249C34076FE7Q28552445-CBE7E0B4-1099-4B2F-A621-0FD40457C162Q29247933-E8054D4E-E99A-4A7D-A0C0-8EBDE800631FQ30238631-5A2B2830-1350-448C-9971-1E5FA470E448Q30240224-8D2A72A3-E982-4A33-B451-6D9DE3A15577Q30248290-AF2C6E0E-DB4B-4B9F-9214-B3107F8CA0A3Q30275531-155B46BF-9E76-47F3-902D-B94D9CBD4348Q30363884-150A99D8-EEBE-4E8D-ACB2-C7E78DA9FC5DQ30490373-8F5B4296-9442-49C9-B412-512D330AF921Q30992330-22E7F8DC-009D-46BC-9D33-1B0320A0DE23Q31009812-2C4E9638-4FB4-4133-BAA0-71F72788FA50Q31047368-6AC28FBE-B99E-4616-90C5-3987856A442BQ31114160-9AD794C7-8EFD-464F-BB7D-AAB84B94CAF0Q31145197-1368A153-719F-45BC-8EF1-DFA5C47759C4Q31156580-3512B6EF-129B-420A-8D0B-987ED74338E3Q33644102-61FFBC9B-B080-4440-A2A0-F2406ADDC48CQ33663081-C13D2F4C-59DD-4E21-9FBC-2BCD98C5E781Q33780795-11321513-0542-48D3-8AA7-58AF673E38F4Q33861317-771E7774-0672-4240-8D74-6ACA15124226Q33886064-EF19C978-9E25-46DD-B263-B558B8879150Q34803882-A2042B61-BE17-43BF-815C-7EF5A559A992Q35111183-98492C56-FF37-4AA5-980C-21A66559A47AQ35627196-C3C1D795-1730-453E-9CA8-A7C169F034A5Q35698461-6E1DAA1E-0AEA-4AEF-85D8-7E41B1839138Q35738018-F284FE26-9956-41C0-9C37-EDA0C049AAFBQ35739435-67354B3F-6B80-4BFB-A16D-7D05ED7B9397Q35751338-4B20FFEA-DC9C-4E78-BC69-756B109725B8Q35763747-5C290C8F-A2EC-4450-9553-8540826100D4Q35839054-80324659-2DE3-4921-95E6-706E48B04554Q35843718-1BAC3259-EFC9-4AD3-B485-ADCF80346C73
P2860
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effect of treatment delay, age ...... nt data from randomised trials
@ast
Effect of treatment delay, age ...... nt data from randomised trials
@en
Effect of treatment delay, age ...... nt data from randomised trials
@nl
type
label
Effect of treatment delay, age ...... nt data from randomised trials
@ast
Effect of treatment delay, age ...... nt data from randomised trials
@en
Effect of treatment delay, age ...... nt data from randomised trials
@nl
prefLabel
Effect of treatment delay, age ...... nt data from randomised trials
@ast
Effect of treatment delay, age ...... nt data from randomised trials
@en
Effect of treatment delay, age ...... nt data from randomised trials
@nl
P2093
P2860
P31
P50
P921
P3181
P1433
P1476
Effect of treatment delay, age ...... nt data from randomised trials
@en
P2093
Barbara Tilley
Colin Baigent
Danilo Toni
Erich Bluhmki
Geoff Cohen
Gordon Murray
Gregory Albers
Gregory J del Zoppo
James Grotta
Jean Marc Olivot
P2860
P304
P3181
P356
10.1016/S0140-6736(14)60584-5
P407
P50
P577
2014-11-29T00:00:00Z